Details
Product Name in the RMS: Co-Dalnessa 4 mg/ 1.25 mg/ 5 mg
MR Number: HU/H/0342/002
Date of outcome: 23.10.2013
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Known Active Substance Initial Application Fixed Combination Chemical Substance Prescription Only |
Active Substances |
amlodipine besilate 5 mg indapamide 1,25 mg perindopril tert-butylamine 4 mg |
Form | Tablet |
MA Holder in the RMS | Krka, d.d., Novo mesto |
RMS | Hungary |
Date of last change | 20.08.2020 |
ATC-Code |
C02N COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02 |
CMS Country | Domestic Product Name |
---|---|
Bulgaria | Co-Amlessa |
Czech Republic | Amlecombi 4 mg/ 5 mg/ 1.25 mg tablety |
Estonia | CO-DALNESSA |
Latvia | Co-Amlessa 4 mg/5 mg/1,25 mg tabletes |
Lithuania | Co-Amlessa 4 mg/5 mg/1,25 mg tabletÄ—s |
Poland | Co-Amlessa |
Romania | Co-Amlessa 4 mg/ 1.25 mg/ 5 mg comprimate |
Slovak Republic | Co-Amlessa 4 mg/5 mg/1,25 mg tablety |
Slovenia |
Documents | |
---|---|
PAR: | HU_H_0342_002_PAR.pdf (17.02.2014) |